Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 164

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 164
---
800,952(14) |     | 6.7%          |

*Less than one percent.

(1)Unless otherwise noted, the business address of each of our directors and executive officers is 300 Conshohocken State Rd., Suite 200, W. Conshohocken, PA 19428.

(2)Includes 793,173 common shares held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. Dr. Raza Bokhari may be deemed the beneficial owner of securities held by RBx Capital, LP. Includes 262,500 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

<div align='center'>- 115 -</div>

(3)Includes 130,000 common shares underlying stock options and 24,000 common shares underlying Public Warrants that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

(4)Includes 65,000 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

(5)Includes 80,000 common shares underlying stock options and 24,000 common shares underlying Public Warrants that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

(6)Includes 28,750 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

(7)Includes 28,750 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

(8)Includes 28,750 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

(9)Includes 28,750 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

(10)Includes 28,750 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

(11)Includes 28,750 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days of the date of this offering circular.

(12)Includes 2,914,330